Effects of omega-3 polyunsaturated fatty acids on inflammatory markers in COPD (Retraction in: Chest (2008) 134:4 (893))

Chest

Volumn 128, Issue 6, 2005, Pages 3817-3827

  Matsuyama, Wataru ^a   Mitsuyama, Hideo ^a   Watanabe, Masaki ^a   Oonakahara, Ken Ichi ^a   Higashimoto, Ikkou ^a   Osame, Mitsuhiro ^a   Arimura, Kimiyoshi ^a  

^a KAGOSHIMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Exacerbation; Interleukin 8; Leukotriene B4; Tumor necrosis factor

Indexed keywords

AUTACOID; INTERLEUKIN 8; LEUKOTRIENE B4; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTERIAL OXYGEN SATURATION; ARTICLE; BLOOD LEVEL; BORG SCALE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIARRHEA; DIET SUPPLEMENTATION; DYSPNEA; FAT INTAKE; FEMALE; HUMAN; INFLAMMATION; MALE; MULTIPLE REGRESSION; NAUSEA; NUTRITIONAL SUPPORT; PRIORITY JOURNAL; PULSE OXIMETRY; RATING SCALE; SAFETY; SPUTUM LEVEL; SYMPTOM; WALKING;

EID: 30344449442     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.128.6.3817     Document Type: Article

References (58)

1. Barnes PJ, Hansel TT. Prospects for new drugs for chronic obstructive pulmonary disease. Lancet 2004; 364:985-996
2. Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 2004; 364:613-620
3. Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 2003; 22:672-688
4. Saetta M, Turato G, Maestrelli P, et al. Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163:1304-1309
5. Rutgers SR, Postma DS, ten Hacken NH, et al. Ongoing airway inflammation in patients with COPD who do not currently smoke. Chest 2000; 117(Suppl):262S
6. Schols AM, Soeters PB, Dingemans AM, et al. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis 1993; 147:1151-1156
7. Shoup R, Dalsky G, Warner S, et al. Body composition and health-related quality of life in patients with obstructive airways disease. Eur Respir J 1997; 10:1576-1580
8. Schols AM, Slangen J, Volovics L, et al. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157:1791-1797
9. de Godoy I, Donahoe M, Calhoun WJ, et al. Elevated TNF-α production by peripheral blood monocytes of weight-losing COPD patients. Am J Respir Crit Care Med 1996; 153:633-637
10. Schols AM. Nutritional and metabolic modulation in chronic obstructive pulmonary disease management. Eur Respir J Suppl 2003; 46:81s-86s
11. Frankfort JD, Fischer CE, Stansbury DW, et al. Effects of high- and low-carbohydrate meals on maximum exercise performance in chronic airflow obstruction. Chest 1991; 100:792-795
12. Kelley DS. Modulation of human immune and inflammatory responses by dietary fatty acids. Nutrition 2001; 17:669-673
13. Meydani SN. Modulation of cytokine production by dietary polyunsaturated fatty acids. Proc Soc Exp Biol Med 1992; 200:189-193
14. Grimble RF. Nutritional modulation of cytokine biology. Nutrition 1998; 14:634-640
15. Gadek JE, DeMichele SJ, Karlstad MD, et al. Effect of enteral feeding with eicosapentaenoic acid, γ-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome: Enteral Nutrition in ARDS Study Group. Crit Care Med 1999; 27:1409-1420
16. Pacht ER, DeMichele SJ, Nelson JL, et al. Enteral nutrition with eicosapentaenoic acid, γ-linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Crit Care Med 2003; 31:491-500
17. Current best practice for nebuliser treatment: the Nebulizer Project Group of the British Thoracic Society Standards of Care Committee. Thorax 1997; 52(Suppl):S1-S3
18. Creutzberg EC, Schols AM, Weling-Scheepers CA, et al. Characterization of nonresponse to high caloric oral nutritional therapy in depleted patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161:745-752
19. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166:111-117
20. Jones PW, Quirk FH, Baveystock CM, et al. A self-complete measure of health status for chronic airflow limitation: the St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992; 145:1321-1327
21. Bach PB, Brown C, Gelfand SE, et al. Management of acute exacerbations of chronic obstructive pulmonary disease: a summary and appraisal of published evidence. Ann Intern Med 2001; 134:600-620
22. Stockley RA, Bayley D, Hill SL, et al. Assessment of airway neutrophils by sputum colour: correlation with airways inflammation. Thorax 2001; 56:366-372
23. Altman DG, Gore SM, Gardner MJ, et al. Statistical guidelines for contributors to medical journals. BMJ (Clin Res Ed) 1983; 286:1489-1493
24. Schols AM, Wesseling G, Kester AD, et al. Dose dependent increased mortality risk in COPD patients treated with oral glucocorticoids. Eur Respir J 2001; 17:337-342
25. Nishimura K, Izumi T, Tsukino M, et al. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002; 121:1434-1440
26. Oga T, Nishimura K, Tsukino M, et al. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care Med 2003; 167:544-549
27. Yokomizo T, Kato K, Terawaki K, et al. A second leukotriene B(4) receptor, BLT2: a new therapeutic target in inflammation and immunological disorders J Exp Med 2000; 192:421-432
28. 4 receptor involves both αi and α16, but not αq or α11 G-protein submits. Biochem J 1998; 335:15-18
29. Montuschi P, Kharitonov SA, Ciabattoni G, et al. Exhaled leukotrienes and prostaglandins in COPD. Thorax 2003; 58:585-588
30. Sperling RI, Benincaso AI, Knoell CT, et al. Dietary omega-3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils. J Clin Invest 1993; 91:651-660
31. Stenson WF, Cort D, Rodgers J, et al. Dietary supplementation with fish oil in ulcerative colitis. Ann Intern Med 1992; 116:609-614
32. Chen G, Goeddel DV. TNF-R1 signaling: a beautiful pathway. Science 2002; 296:1634-1635
33. Krunkosky TM, Fischer BM, Martin LD, et al. Effects of TNF-α on expression of ICAM-1 in human airway epithelial cells in vitro: signaling pathways controlling surface and gene expression. Am J Respir Cell Mol Biol 2000; 22:685-692
34. Paine R III, Morris SB, Jin H, et al. ICAM-1 facilitates alveolar macrophage phagocytic activity through effects on migration over the AEC surface. Am J Physiol Lung Cell Mol Physiol 2002; 283:L180-L187
35. Keatings VM, Collins PD, Scott DM, et al. Differences in interleukin-8 and tumor necrosis factor-α in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996; 153:530-534
36. Spruit MA, Gosselink R, Troosters T, et al. Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I. Thorax 2003; 58:752-756
37. Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines: CXC and CC chemokines. Adv Immunol 1994; 55:97-179
38. Takizawa H, Tanaka M, Takami K, et al. Increased expression of inflammatory mediators in small-airway epithelium from tobacco smokers. Am J Physiol Lung Cell Mol Physiol 2000; 278:L906-L913
39. Mio T, Romberger DJ, Thompson AB, et al. Cigarette smoke induces interleukin-8 release from human bronchial epithelial cells. Am J Respir Crit Care Med 1997; 155:1770-1776
40. Matsumoto K, Hashimoto S, Gon Y, et al. Proinflammatory cytokine-induced and chemical mediator-induced IL-8 expression in human bronchial epithelial cells through p38 mitogen-activated protein kinase-dependent pathway. J Allergy Clin Immunol 1998; 101:82.5-831
41. Ikonen E. Roles of lipid rafts in membrane transport. Curr Opin Cell Biol 2001; 13:470-477
42. Jump DB. The biochemistry of n-3 polyunsaturated fatty acids. J Biol Chem 2002; 277:8755-8758
43. Fan YY, Ly LH, Barhoumi R, et al. Dietary docosahexaenoic acid suppresses T cell protein kinase CO lipid raft recruitment and IL-2 production. J Immunol 2004; 173:6151-6160
44. Switzer KC, McMurray DN, Chapkin RS. Effects of dietary n-3 polyunsaturated fatty acids on T-cell membrane composition and function. Lipids 2004; 39:1163-1170
45. Guermouche B, Yessoufou A, Soulimane N, et al. n-3 fatty acids modulate T-cell calcium signaling in obese macrosomic rats. Obes Res 2004; 12:1744-1753
46. Nyby MD, Hori MT, Ormsby B, et al. Eicosapentaenoic acid inhibits Ca2+ mobilization and PKC activity in vascular smooth muscle cells. Am J Hypertens 2003; 16:708-714
47. Niu SL, Mitchell DC, Lim SY, et al. Reduced G protein-coupled signaling efficiency in retinal rod oviter segments in response to n-3 fatty acid deficiency. J Biol Chem 2004; 279:31098-31104
48. Robinson DR, Urakaze M, Huang R, et al. Dietary marine lipids suppress continuous expression of interleukin-1 beta gene transcription. Lipids 1996; 31(Suppl):S23-S31
49. Bagga D, Wang L, Farias-Eisner R, et al. Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc Natl Acad Sci U S A 2003; 100:1751-1756
50. Irons R, Fritsche KL. Omega-3 polyunsaturated fatty acids impair in vivo interferon-γ responsiveness via diminished receptor signaling. J Infect Dis 2005; 191:481-486
51. Calviello G, Di Nicuolo F, Gragnoli S, et al. n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1α induction pathway. Carcinogenesis 2004; 25:2303-2310
52. Lee JY, Plakidas A, Lee WH, et al. Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids. J Lipid Res 2003; 44:479-486
53. Babcock TA, Kurland A, Helton WS, et al. Inhibition of activator protein-1 transcription factor activation by omega-3 fatty acid modulation of mitogen-activated protein kinase signaling kinases. JPEN J Parenter Enteral Nutr 2003; 27:176-180
54. Lo CJ, Chiu KC, Fu M, et al. Fish oil decreases macrophage tumor necrosis factor gene transcription by altering the NF KB activity. J Surg Res 1999; 82:216-221
55. Ross JA, Maingay JP, Fearon KC, et al. Eicosaperitaenoic acid perturbs signalling via the NFκB transcriptional pathway in pancreatic tumour cells. Int J Oncol 2003; 23:1733-1738
56. Kris-Etherton PM, Harris WS, Appel LJ. Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association. Arterioscler Thromb Vasc Biol 2003; 23:151-152
57. Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002; 106:2747-2757
58. Siscovick DS, Raghunathan TE, King I, et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 1995; 274:1363-1367